By Ben Butkus

Startup molecular diagnostics shop GenturaDx presented data today demonstrating that an assay for herpes simplex virus run on the beta version of its fully integrated, sample-to-answer molecular testing platform has sensitivity and specificity comparable to or greater than three commercially available HSV assays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.